Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Head and Neck Cancer|Melanoma|Breast Cancer|Bladder Cancer|Ovarian Carcinoma|Cervical Carcinoma|Lung Cancer
Interventions: DRUG: Recombinant L-IFN adenovirus injection
Sponsor: Shanghai Fengxian District Central Hospital
Collaborators: Shanghai Yuansong Biotechnology Co., LTD